Mastering repeatability in cell culture with INTEGRA Biosciences’ WELLJET peristaltic pump dispenser

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it

Patients with single-site synchronous oligometastatic non-small cell lung cancer (NSCLC) had better overall survival (OS) when they received surgery for their primary tumor, a retrospective

The FDA granted accelerated approval to the bispecific antibody elranatamab (Elrexfio) for relapsed/refractory multiple myeloma treated with at least four prior regimens. A B-cell maturation